Literature DB >> 23229817

Mouse models of lung squamous cell carcinomas.

Michael S You1, Lucina C Rouggly, Ming You, Yian Wang.   

Abstract

Although many mouse models of lung adenocarcinoma exist, only a few mouse lung squamous cell carcinoma models have been developed. Since most clinical chemoprevention trials of lung cancer are performed in subjects with bronchial dysplasia, development of a lung squamous cell carcinoma mouse model sufficient for chemoprevention studies is a high priority. We have shown that lung squamous cell carcinomas can be induced chemically in several strains of mice (1), and that this chemically induced lung squamous cell carcinoma model is applicable to cancer chemoprevention studies. Recently, Ji et al. (2) have shown that simultaneous activation of KrasG12D and inactivation of Lkb1 results in a broader histological range of lung tumors, with approximately 50 % of the lung tumors being squamous cell carcinomas. Here, we review the application of mouse lung squamous cell carcinoma models with different stages of squamous lesions and squamous cell carcinomas to cancer development and chemoprevention studies.

Entities:  

Mesh:

Year:  2013        PMID: 23229817     DOI: 10.1007/s10555-012-9406-4

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  6 in total

Review 1.  From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung Cancers.

Authors:  Adi F Gazdar; Fred R Hirsch; John D Minna
Journal:  J Thorac Oncol       Date:  2015-12-24       Impact factor: 15.609

Review 2.  Mouse models for lung cancer.

Authors:  Min-chul Kwon; Anton Berns
Journal:  Mol Oncol       Date:  2013-02-19       Impact factor: 6.603

3.  Endothelial cell-specific chemotaxis receptor (ECSCR) enhances vascular endothelial growth factor (VEGF) receptor-2/kinase insert domain receptor (KDR) activation and promotes proteolysis of internalized KDR.

Authors:  Sreenivasulu Kilari; Indulekha Remadevi; Baofeng Zhao; Jing Pan; Robert Miao; Ramani Ramchandran; Paula E North; Ming You; Nader Rahimi; George A Wilkinson
Journal:  J Biol Chem       Date:  2013-02-07       Impact factor: 5.157

4.  Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype.

Authors:  Marta Larrayoz; Ruben Pio; María J Pajares; Isabel Zudaire; Daniel Ajona; Oriol Casanovas; Luis M Montuenga; Jackeline Agorreta
Journal:  EMBO Mol Med       Date:  2014-02-05       Impact factor: 12.137

Review 5.  Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models.

Authors:  William K Decker; Rodrigo F da Silva; Mayra H Sanabria; Laura S Angelo; Fernando Guimarães; Bryan M Burt; Farrah Kheradmand; Silke Paust
Journal:  Front Immunol       Date:  2017-08-02       Impact factor: 7.561

6.  NTCU induced pre-malignant and malignant stages of lung squamous cell carcinoma in mice model.

Authors:  Muhammad Asyaari Zakaria; Nor Fadilah Rajab; Eng Wee Chua; Gayathri Thevi Selvarajah; Siti Fathiah Masre
Journal:  Sci Rep       Date:  2021-11-18       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.